GenomOncology, a precision medicine software company, and Genomenon, a leading genomic intelligence company, announced a strategic partnership aimed at streamlining germline variant classification and...
GenomOncology announced that the GenomOncology (GO) Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease (MRD)...
GenomOncology announced that their Precision Oncology Platform now integrates patients' prior intervention eligibility criteria to further advance their treatment matching algorithm and decision support...
